Nanoscale strategies: Treatment for peripheral vascular disease and critical limb ischemia

ACS Nano

Volumn 9, Issue 4, 2015, Pages 3436-3452

  Tu, Chengyi ^a   Das, Subhamoy ^a   Baker, Aaron B ^a   Zoldan, Janeta ^a   Suggs, Laura J ^a  

^a The University of Texas at Austin   (United States)

Author keywords

cell therapy; critical limb ischemia; gene delivery; growth factor; nanomaterials; nanomedicine; nanoparticles; peripheral vascular disease; stem cells; therapeutic angiogenesis; tissue engineering; vascular graft

Indexed keywords

CELLS; CYTOLOGY; DISEASE CONTROL; DISEASES; GENE THERAPY; GENE TRANSFER; GENES; GRAFTS; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; OXYGEN SUPPLY; PROTEINS; STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

CELL THERAPY; CRITICAL LIMB ISCHEMIA; GENE DELIVERY; GROWTH FACTOR; PERIPHERAL VASCULAR DISEASE; THERAPEUTIC ANGIOGENESIS; VASCULAR GRAFTS;

CELL ENGINEERING;

ANIMAL; BIOLOGICAL THERAPY; GENETICS; HUMAN; ISCHEMIA; LIMB; NANOMEDICINE; PATHOLOGY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; EXTREMITIES; HUMANS; ISCHEMIA; NANOMEDICINE; PERIPHERAL VASCULAR DISEASES; TISSUE ENGINEERING;

EID: 84928941108     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn507269g     Document Type: Article

References (157)

1. Roger, V. L.; Go, A. S.; Lloyd-Jones, D. M.; Adams, R. J.; Berry, J. D.; Brown, T. M.; Carnethon, M. R.; Dai, S.; de Simone, G.; Ford, E. S. Heart Disease and Stroke Statistics-2011 Update: A Report from the American Heart Association Circulation 2011, 123, e18-e209
2. Ouriel, K. Peripheral Arterial Disease Lancet 2001, 358, 1257-1264
3. Minar, E. Critical Limb Ischaemia Hamostaseologie 2009, 29, 102-9
4. Norgren, L.; Hiatt, W. R.; Dormandy, J. A.; Nehler, M. R.; Harris, K. A.; Fowkes, F. G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (Tasc II) J. Vasc. Surg. 2007, 45 (Suppl S) S5-67
5. Deveza, L.; Choi, J.; Yang, F. Therapeutic Angiogenesis for Treating Cardiovascular Diseases Theranostics 2012, 2, 801-814
6. Zilla, P.; Bezuidenhout, D.; Human, P. Prosthetic Vascular Grafts: Wrong Models, Wrong Questions and No Healing Biomaterials 2007, 28, 5009-5027
7. Shimamura, M.; Nakagami, H.; Taniyama, Y.; Morishita, R. Gene Therapy for Peripheral Arterial Disease Expert Opin. Biol. Ther. 2014, 14, 1175-1184
8. Raval, Z.; Losordo, D. W. Cell Therapy of Peripheral Arterial Disease: From Experimental Findings to Clinical Trials Circ. Res. 2013, 112, 1288-1302
9. Morishita, R.; Makino, H.; Aoki, M.; Hashiya, N.; Yamasaki, K.; Azuma, J.; Taniyama, Y.; Sawa, Y.; Kaneda, Y.; Ogihara, T. Phase I/Iia Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia Arterioscl. Throm. Vas. 2011, 31, 713-U507
10. Skora, J.; Barc, P.; Pupka, A.; Dawiskiba, T.; Korta, K.; Albert, M.; Szyber, P. Transplantation of Autologous Bone Marrow Mononuclear Cells with VEGF Gene Improves Diabetic Critical Limb Ischaemia Endokrynol. Pol. 2013, 64, 129-138
11. Gupta, R.; Tongers, J.; Losordo, D. W. Human Studies of Angiogenic Gene Therapy Circ. Res. 2009, 105, 724-736
12. Cuevas, P.; Carceller, F.; Ortega, S.; Zazo, M.; Nieto, I.; Gimenezgallego, G. Hypotensive Activity of Fibroblast Growth-Factor Science 1991, 254, 1208-1210
13. Thurston, G.; Suri, C.; Smith, K.; McClain, J.; Sato, T. N.; Yancopoulos, G. D.; McDonald, D. M. Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1 Science 1999, 286, 2511-2514
14. Rissanen, T. T.; Markkanen, J. E.; Arve, K.; Rutanen, J.; Kettunen, M. I.; Vajanto, I.; Jauhiainen, S.; Cashion, L.; Gruchala, M.; Narvanen, O. Fibroblast Growth Factor-4 Induces Vascular Permeability, Angiogenesis, and Arteriogenesis in a Rabbit Hind Limb Ischemia Model FASEB J. 2002, 16, 100
15. Aicher, A.; Brenner, W.; Zuhayra, M.; Badorff, C.; Massoudi, S.; Assmus, B.; Eckey, T.; Henze, E.; Zeiher, A. M.; Dimmeler, S. Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling Circulation 2003, 107, 2134-2139
16. Li, S. D.; Huang, L. Pharmacokinetics and Biodistribution of Nanoparticles Mol. Pharmaceutics 2008, 5, 496-504
17. De Jong, W. H.; Borm, P. J. A. Drug Delivery and Nanoparticles: Applications and Hazards Int. J. Nanomedicine 2008, 3, 133-149
18. Arvizo, R. R.; Miranda, O. R.; Moyano, D. F.; Walden, C. A.; Giri, K.; Bhattacharya, R.; Robertson, J. D.; Rotello, V. M.; Reid, J. M.; Mukherjee, P. Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles PLoS One 2011, 6 e24374
19. El-Sayed, I. H.; Huang, X.; El-Sayed, M. A. Surface Plasmon Resonance Scattering and Absorption of Anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer Nano Lett. 2005, 5, 829-34
20. Dinauer, N.; Balthasar, S.; Weber, C.; Kreuter, J.; Langer, K.; von Briesen, H. Selective Targeting of Antibody-Conjugated Nanoparticles to Leukemic Cells and Primary T-Lymphocytes Biomaterials 2005, 26, 5898-906
21. Begent, R. H. J.; Verhaar, M. J.; Chester, K. A.; Casey, J. L.; Green, A. J.; Napier, M. P.; HopeStone, L. D.; Cushen, N.; Keep, P. A.; Johnson, C. J. Clinical Evidence of Efficient Tumor Targeting Based on Single-Chain Fv Antibody Selected from a Combinatorial Library Nat. Med. 1996, 2, 979-984
22. Robert, S.; Gysemans, C.; Takiishi, T.; Korf, H.; Spagnuolo, I.; Sebastiani, G.; Van Huynegem, K.; Steidler, L.; Caluwaerts, S.; Demetter, P. Oral Delivery of Glutamic Acid Decarboxylase (Gad)-65 and Il10 by Lactococcus Lactis Reverses Diabetes in Recent-Onset Nod Mice Diabetes 2014, 63, 2876-2887
23. Lin, Y. H.; Liang, H. F.; Chung, C. K.; Chen, M. C.; Sung, H. W. Physically Crosslinked Alginate/N,O-Carboxymethyl Chitosan Hydrogels with Calcium for Oral Delivery of Protein Drugs Biomaterials 2005, 26, 2105-2113
24. Rekha, M. R.; Sharma, C. P. Oral Delivery of Therapeutic Protein/Peptide for Diabetes-Future Perspectives Int. J. Pharm. 2013, 440, 48-62
25. Han, L.; Tang, C.; Yin, C. H. Oral Delivery of shRNA and siRNA via Multifunctional Polymeric Nanoparticles for Synergistic Cancer Therapy Biomaterials 2014, 35, 4589-4600
26. Akhtar, S. Oral Delivery of siRNA and Antisense Oligonucleotides J. Drug Target. 2009, 17, 491-495
27. Gao, W. W.; Chan, J. M.; Farokhzad, O. C. PH-Responsive Nanoparticles for Drug Delivery Mol. Pharmaceutics 2010, 7, 1913-1920
28. Lux, C. D.; Joshi-Barr, S.; Nguyen, T.; Mahmoud, E.; Schopf, E.; Fomina, N.; Almutairi, A. Biocompatible Polymeric Nanoparticles Degrade and Release Cargo in Response to Biologically Relevant Levels of Hydrogen Peroxide J. Am. Chem. Soc. 2013, 134, 15758-15764
29. Hasan, A.; Memic, A.; Annabi, N.; Hossain, M.; Paul, A.; Dokmeci, M. R.; Dehghani, F.; Khademhosseini, A. Electrospun Scaffolds for Tissue Engineering of Vascular Grafts Acta Biomater. 2014, 10, 11-25
30. Lazarous, D. F.; Shou, M.; Scheinowitz, M.; Hodge, E.; Thirumurti, V.; Kitsiou, A. N.; Stiber, J. A.; Lobo, A. D.; Hunsberger, S.; Guetta, E. Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury Circulation 1996, 94, 1074-1082
31. Marui, A.; Tabata, Y.; Kojima, S.; Yamamoto, M.; Tambara, K.; Nishina, T.; Saji, Y.; Inui, K. I.; Hashida, T.; Yokoyama, S. Novel Approach to Therapeutic Angiogenesis for Patients with Critical Limb Ischemia by Sustained Release of Basic Fibroblast Growth Factor Using Biodegradable Gelatin Hydrogel-An Initial Report of the Phase I-Iia Study Circ. J. 2007, 71, 1181-1186
32. Lazarous, D. F.; Unger, E. F.; Epstein, S. E.; Stine, A.; Arevalo, J. L.; Chew, E. Y.; Quyyumi, A. A. Basic Fibroblast Growth Factor in Patients with Intermittent Claudication: Results of a Phase I Trial J. Am. Coll. Cardiol. 2000, 36, 1239-1244
33. Golub, J. S.; Kim, Y. T.; Duvall, C. L.; Bellamkonda, R. V.; Gupta, D.; Lin, A. S.; Weiss, D.; Taylor, W. R.; Guldberg, R. E. Sustained VEGF Delivery via PLGA Nanoparticles Promotes Vascular Growth Am. J. Physiol.: Heart Circ. Physiol. 2010, 298, H1959-H1965
34. d'Angelo, I.; Garcia-Fuentes, M.; Parajo, Y.; Welle, A.; Vantus, T.; Horvath, A.; Bokonyi, G.; Keri, G.; Alonso, M. J. Nanoparticles Based on PLGA:Poloxamer Blends for the Delivery of Proangiogenic Growth Factors Mol. Pharmaceutics 2010, 7, 1724-1733
35. Kim, J.; Cao, L.; Shvartsman, D.; Silva, E. A.; Mooney, D. J. Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic Angiogenesis Nano Lett. 2011, 11, 694-700
36. Sun, Z. C.; Huang, P.; Tong, G.; Lin, J.; Jin, A.; Rong, P. F.; Zhu, L.; Nie, L. M.; Niu, G.; Cao, F. VEGF-Loaded Graphene Oxide as Theranostics for Multi-Modality Imaging-Monitored Targeting Therapeutic Angiogenesis of Ischemic Muscle Nanoscale 2013, 5, 6857-6866
37. Peer, D.; Karp, J. M.; Hong, S.; FarokHzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
38. Xie, J.; Wang, H.; Wang, Y.; Ren, F.; Yi, W.; Zhao, K.; Li, Z.; Zhao, Q.; Liu, Z.; Wu, H. Induction of Angiogenesis by Controlled Delivery of Vascular Endothelial Growth Factor Using Nanoparticles Cardiovasc. Ther. 2013, 31, e12-18
39. Zhang, J.; Postovit, L. M.; Wang, D. S.; Gardiner, R. B.; Harris, R.; Abdul, M. M.; Thomas, A. A. In Situ Loading of Basic Fibroblast Growth Factor within Porous Silica Nanoparticles for a Prolonged Release Nanoscale Res. Lett. 2009, 4, 1297-1302
40. Ramchandani, M.; Robinson, D. In Vitro and in Vivo Release of Ciprofloxacin from PLGA 50:50 Implants J. Controlled Release 1998, 54, 167-175
41. Jang, E.; Albadawi, H.; Watkins, M. T.; Edelman, E. R.; Baker, A. B. Syndecan-4 Proteoliposomes Enhance Fibroblast Growth Factor-2 (FGF-2)-Induced Proliferation, Migration, and Neovascularization of Ischemic Muscle Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 1679-1684
42. Das, S.; Singh, G.; Baker, A. B. Overcoming Disease-Induced Growth Factor Resistance in Therapeutic Angiogenesis Using Recombinant Co-Receptors Delivered by a Liposomal System Biomaterials 2014, 35, 196-205
43. Baluk, P.; Lee, C. G.; Link, H.; Ator, E.; Haskell, A.; Elias, J. A.; McDonald, D. M. Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways Am. J. Pathol. 2004, 165, 1071-1085
44. Chung, E.; Ricles, L. M.; Stowers, R. S.; Nam, S. Y.; Emelianov, S. Y.; Suggs, L. J. Multifunctional Nanoscale Strategies for Enhancing and Monitoring Blood Vessel Regeneration Nano Today 2012, 7, 514-531
45. Maggio, I.; Holkers, M.; Liu, J.; Janssen, J. M.; Chen, X.; Goncalves, M. A. Adenoviral Vector Delivery of RNA-Guided CRISPR/Cas9 Nuclease Complexes Induces Targeted Mutagenesis in a Diverse Array of Human Cells Sci. Rep. 2014, 4, 5105
46. McTiernan, C. F.; Mathier, M. A.; Zhu, X.; Xiao, X.; Klein, E.; Swan, C. H.; Mehdi, H.; Gibson, G.; Trichel, A. M.; Glorioso, J. C. Myocarditis Following Adeno-Associated Viral Gene Expression of Human Soluble Tnf Receptor (Tnfrii-Fc) in Baboon Hearts Gene Ther. 2007, 14, 1613-1622
47. Yockman, J. W.; Kastenmeier, A.; Erickson, H. M.; Brumbach, J. G.; Whitten, M. G.; Albanil, A.; Li, D. Y.; Kim, S. W.; Bull, D. A. Novel Polymer Carriers and Gene Constructs for Treatment of Myocardial Ischemia and Infarction J. Controlled Release 2008, 132, 260-266
48. Thomas, C. E.; Ehrhardt, A.; Kay, M. A. Progress and Problems with the Use of Viral Vectors for Gene Therapy Nat. Rev. Genet. 2003, 4, 346-58
49. Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S. Design and Development of Polymers for Gene Delivery Nat. Rev. Drug Discovery 2005, 4, 581-593
50. Zhang, X. Q.; Wang, X. L.; Huang, S. W.; Zhuo, R. X.; Liu, Z. L.; Mao, H. Q.; Leong, K. W. In Vitro Gene Delivery Using Polyamidoamine Dendrimers with a Trimesyl Core Biomacromolecules 2005, 6, 341-350
51. Cheng, Y. Y.; Zhao, L. B.; Li, Y. W.; Xu, T. W. Design of Biocompatible Dendrimers for Cancer Diagnosis and Therapy: Current Status and Future Perspectives Chem. Soc. Rev. 2011, 40, 2673-2703
52. Godbey, W. T.; Wu, K. K.; Mikos, A. G. Poly(Ethylenimine) and Its Role in Gene Delivery J. Controlled Release 1999, 60, 149-160
53. Ogris, M.; Brunner, S.; Schuller, S.; Kircheis, R.; Wagner, E. PEGylated DNA/Transferrin-PEI Complexes: Reduced Interaction with Blood Components, Extended Circulation in Blood and Potential for Systemic Gene Delivery Gene Ther. 1999, 6, 595-605
54. Zhang, L. F.; Chen, Z. Z.; Li, Y. F. Dual-Degradable Disulfide-Containing PEI-Pluronic/DNA Polyplexes: Transfection Efficiency and Balancing Protection and DNA Release Int. J. Nanomed. 2013, 8, 3689-3701
55. Song, Y. Y.; Lou, B.; Zhao, P.; Lin, C. Multifunctional Disulfide-Based Cationic Dextran Conjugates for Intravenous Gene Delivery Targeting Ovarian Cancer Cells Mol. Pharmaceutics 2014, 11, 2250-2261
56. Tang, Q.; Cao, B.; Lei, X.; Sun, B. B.; Zhang, Y. Q.; Cheng, G. Dextran-Peptide Hybrid for Efficient Gene Delivery Langmuir 2014, 30, 5202-5208
57. Trentin, D.; Hall, H.; Wechsler, S.; Hubbell, J. A. Peptide-Matrix-Mediated Gene Transfer of an Oxygen-Insensitive Hypoxia-Inducible Factor-1alpha Variant for Local Induction of Angiogenesis Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 2506-2511
58. Tang, D. W.; Yu, S. H.; Ho, Y. C.; Mi, F. L.; Kuo, P. L.; Sung, H. W. Heparinized Chitosan/Poly(Gamma-Glutamic Acid) Nanoparticles for Multi-Functional Delivery of Fibroblast Growth Factor and Heparin Biomaterials 2010, 31, 9320-9332
59. Pissuwan, D.; Niidome, T.; Cortie, M. B. The Forthcoming Applications of Gold Nanoparticles in Drug and Gene Delivery Systems J. Controlled Release 2011, 149, 65-71
60. Guo, S.; Huang, Y.; Jiang, Q.; Sun, Y.; Deng, L.; Liang, Z.; Du, Q.; Xing, J.; Zhao, Y.; Wang, P. C. Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte ACS Nano 2010, 4, 5505-5511
61. Ghosh, P. S.; Kim, C. K.; Han, G.; Forbes, N. S.; Rotello, V. M. Efficient Gene Delivery Vectors by Tuning the Surface Charge Density of Amino Acid-Functionalized Gold Nanoparticles ACS Nano 2008, 2, 2213-2218
62. Kim, M. H.; Na, H. K.; Kim, Y. K.; Ryoo, S. R.; Cho, H. S.; Lee, K. E.; Jeon, H.; Ryoo, R.; Min, D. H. Facile Synthesis of Monodispersed Mesoporous Silica Nanoparticles with Ultralarge Pores and Their Application in Gene Delivery ACS Nano 2011, 5, 3568-3576
63. Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C. W.; Lin, V. S. Y. Mesoporous Silica Nanoparticles as Controlled Release Drug Delivery and Gene Transfection Carriers Adv. Drug Delivery Rev. 2008, 60, 1278-1288
64. Pantarotto, D.; Singh, R.; McCarthy, D.; Erhardt, M.; Briand, J. P.; Prato, M.; Kostarelos, K.; Bianco, A. Functionalized Carbon Nanotubes for Plasmid DNA Gene Delivery Angew. Chem. Int. Ed. 2004, 43, 5242-5246
65. Zhi, D. F.; Zhang, S. B.; Cui, S. H.; Zhao, Y. A.; Wang, Y. H.; Zhao, D. F. The Headgroup Evolution of Cationic Lipids for Gene Delivery Bioconjugate Chem. 2013, 24, 487-519
66. Fichert, T.; Regelin, A.; Massing, U. Synthesis and Transfection Properties of Novel Non-Toxic Monocationic Lipids. Variation of Lipid Anchor, Spacer and Head Group Structure Bioorg. Med. Chem. Lett. 2000, 10, 787-791
67. Bajaj, A.; Kondiah, P.; Bhattacharya, S. Design, Synthesis, and in Vitro Gene Delivery Efficacies of Novel Cholesterol-Based Gemini Cationic Lipids and Their Serum Compatibility: A Structure-Activity Investigation J. Med. Chem. 2007, 50, 2432-2442
68. Zhu, K.; Guo, C. F.; Lai, H.; Yang, W. L.; Xia, Y.; Zhao, D.; Wang, C. S. Novel Hyperbranched Polyamidoamine Nanoparticles for Transfecting Skeletal Myoblasts with Vascular Endothelial Growth Factor Gene for Cardiac Repair J. Mater. Sci.: Mater. Med. 2011, 22, 2477-2485
69. Kunath, K.; von Harpe, A.; Fischer, D.; Peterson, H.; Bickel, U.; Voigt, K.; Kissel, T. Low-Molecular-Weight Polyethylenimine as a Non-Viral Vector for DNA Delivery: Comparison of Physicochemical Properties, Transfection Efficiency and in Vivo Distribution with High-Molecular-Weight Polyethylenimine J. Controlled Release 2003, 89, 113-125
70. Moghimi, S. M.; Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A. A Two-Stage Poly(Ethylenimine)-Mediated Cytotoxicity: Implications for Gene Transfer/Therapy Mol. Ther. 2005, 11, 990-995
71. Zhi, D.; Zhang, S.; Cui, S.; Zhao, Y.; Wang, Y.; Zhao, D. The Headgroup Evolution of Cationic Lipids for Gene Delivery Bioconjugate Chem. 2013, 24, 487-519
72. Zhi, D.; Zhang, S.; Wang, B.; Zhao, Y.; Yang, B.; Yu, S. Transfection Efficiency of Cationic Lipids with Different Hydrophobic Domains in Gene Delivery Bioconjugate Chem. 2010, 21, 563-77
73. Duarte, S.; Faneca, H.; Lima, M. C. Folate-Associated Lipoplexes Mediate Efficient Gene Delivery and Potent Antitumoral Activity in Vitro and in Vivo Int. J. Pharm. 2012, 423, 365-377
74. Duarte, S.; Faneca, H.; de Lima, M. C. Non-Covalent Association of Folate to Lipoplexes: A Promising Strategy to Improve Gene Delivery in the Presence of Serum J. Controlled Release 2011, 149, 264-272
75. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery J. Controlled Release 2006, 114, 100-109
76. Jiang, H.; Zhang, T.; Sun, X. Vascular Endothelial Growth Factor Gene Delivery by Magnetic DNA Nanospheres Ameliorates Limb Ischemia in Rabbits J. Surg. Res. 2005, 126, 48-54
77. Kang, S. W.; Lim, H. W.; Seo, S. W.; Jeon, O.; Lee, M.; Kim, B. S. Nanosphere-Mediated Delivery of Vascular Endothelial Growth Factor Gene for Therapeutic Angiogenesis in Mouse Ischemic Limbs Biomaterials 2008, 29, 1109-1117
78. Negishi, Y.; Endo-Takahashi, Y.; Matsuki, Y.; Kato, Y.; Takagi, N.; Suzuki, R.; Maruyama, K.; Aramaki, Y. Systemic Delivery Systems of Angiogenic Gene by Novel Bubble Liposomes Containing Cationic Lipid and Ultrasound Exposure Mol. Pharmaceutics 2012, 9, 1834-1840
79. Negishi, Y.; Matsuo, K.; Endo-Takahashi, Y.; Suzuki, K.; Matsuki, Y.; Takagi, N.; Suzuki, R.; Maruyama, K.; Aramaki, Y. Delivery of an Angiogenic Gene into Ischemic Muscle by Novel Bubble Liposomes Followed by Ultrasound Exposure Pharm. Res. 2011, 28, 712-719
80. Endo-Takahashi, Y.; Negishi, Y.; Nakamura, A.; Ukai, S.; Ooaku, K.; Oda, Y.; Sugimoto, K.; Moriyasu, F.; Takagi, N.; Suzuki, R. Systemic Delivery of miR-126 by miRNA-Loaded Bubble Liposomes for the Treatment of Hindlimb Ischemia Sci. Rep. 2014, 4, 3883
81. Botham, C. M.; Bennett, W. L.; Cooke, J. P. Clinical Trials of Adult Stem Cell Therapy for Peripheral Artery Disease Methodist Debakey Cardiovasc. J. 2013, 9, 201-205
82. Sibbald, B. Death but One Unintended Consequence of Gene-Therapy Trial CMAJ 2001, 164, 1612
83. Liew, A.; O'Brien, T. Therapeutic Potential for Mesenchymal Stem Cell Transplantation in Critical Limb Ischemia Stem Cell Res. Ther. 2012, 3, 28
84. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis Science 1997, 275, 964-967
85. Barry, F. P.; Murphy, J. M. Mesenchymal Stem Cells: Clinical Applications and Biological Characterization Int. J. Biochem. Cell Biol. 2004, 36, 568-584
86. Tscheudschilsuren, G.; Bosserhoff, A. K.; Schlegel, J.; Vollmer, D.; Anton, A.; Alt, V.; Schnettler, R.; Brandt, J.; Proetzel, G. Regulation of Mesenchymal Stem Cell and Chondrocyte Differentiation by MIA Exp. Cell. Res. 2006, 312, 63-72
87. Chiellini, C.; Cochet, O.; Negroni, L.; Samson, M.; Poggi, M.; Ailhaud, G.; Alessi, M. C.; Dani, C.; Amri, E. Z. Characterization of Human Mesenchymal Stem Cell Secretome at Early Steps of Adipocyte and Osteoblast Differentiation BMC Mol. Biol. 2008, 9, 26
88. Gao, Q.; Guo, M.; Jiang, X.; Hu, X.; Wang, Y.; Fan, Y. A Cocktail Method for Promoting Cardiomyocyte Differentiation from Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells Int. 2014, 2014, 162024
89. Friedman, M. S.; Long, M. W. Stem Cell Plasticity: CD34+Hematopoietic Cells and Mesenchymal Stem Cells Undergo Regulated Differentiation into Endothelial Cells Blood 2001, 98, 549a-550a
90. Motukuru, V.; Suresh, K. R.; Vivekanand, V.; Raj, S.; Girija, K. R. Therapeutic Angiogenesis in Buerger's Disease (Thromboangiitis Obliterans) Patients with Critical Limb Ischemia by Autologous Transplantation of Bone Marrow Mononuclear Cells J. Vasc. Surg. 2008, 48, 53S-60S
91. Das, A. K.; Bin Abdullah, B. J.; Dhillon, S. S.; Vijanari, A.; Anoop, C. H.; Gupta, P. K. Intra-Arterial Allogeneic Mesenchymal Stem Cells for Critical Limb Ischemia Are Safe and Efficacious: Report of a Phase I Study World J. Surg. 2013, 37, 915-922
92. Wang, C. Y.; Yang, H. B.; Hsu, H. S.; Chen, L. L.; Tsai, C. C.; Tsai, K. S.; Yew, T. L.; Kao, Y. H.; Hung, S. C. Mesenchymal Stem Cell-Conditioned Medium Facilitates Angiogenesis and Fracture Healing in Diabetic Rats J. Tissue Eng. Regen. Med. 2012, 6, 559-569
93. Wang, Y.; Chen, X.; Cao, W.; Shi, Y. Plasticity of Mesenchymal Stem Cells in Immunomodulation: Pathological and Therapeutic Implications Nat. Immunol. 2014, 15, 1009-1016
94. Otsuru, S.; Gordon, P. L.; Shimono, K.; Jethva, R.; Marino, R.; Phillips, C. L.; Hofmann, T. J.; Veronesi, E.; Dominici, M.; Iwamoto, M. Transplanted Bone Marrow Mononuclear Cells and MSCs Impart Clinical Benefit to Children with Osteogenesis Imperfecta through Different Mechanisms Blood 2012, 120, 1933-1941
95. Barber, C. L.; Iruela-Arispe, M. L. The Ever-Elusive Endothelial Progenitor Cell: Identities, Functions and Clinical Implications Pediatr. Res. 2006, 59, 722-722
96. Yang, F.; Cho, S. W.; Son, S. M.; Bogatyrev, S. R.; Singh, D.; Green, J. J.; Mei, Y.; Park, S.; Bhang, S. H.; Kim, B. S. Genetic Engineering of Human Stem Cells for Enhanced Angiogenesis Using Biodegradable Polymeric Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 3317-3322
97. Lee, J.; Jun, I.; Park, H. J.; Kang, T. J.; Shin, H.; Cho, S. W. Genetically Engineered Myoblast Sheet for Therapeutic Angiogenesis Biomacromolecules 2014, 15, 361-372
98. Gomes, R. S.; das Neves, R. P.; Cochlin, L.; Lima, A.; Carvalho, R.; Korpisalo, P.; Dragneva, G.; Turunen, M.; Liimatainen, T.; Clarke, K. Efficient Pro-Survival/Angiogenic miRNA Delivery by an MRI-Detectable Nanomaterial ACS Nano 2013, 7, 3362-3372
99. Koiwaya, H.; Sasaki, K.; Ueno, T.; Yokoyama, S.; Toyama, Y.; Ohtsuka, M.; Nakayoshi, T.; Mitsutake, Y.; Imaizumi, T. Augmented Neovascularization with Magnetized Endothelial Progenitor Cells in Rats with Hind-Limb Ischemia J. Mol. Cell Cardiol. 2011, 51, 33-40
100. Kang, H. J.; Kim, J. Y.; Lee, H. J.; Kim, K. H.; Kim, T. Y.; Lee, C. S.; Lee, H. C.; Park, T. H.; Kim, H. S.; Park, Y. B. Magnetic Bionanoparticle Enhances Homing of Endothelial Progenitor Cells in Mouse Hindlimb Ischemia Korean Circ. J. 2012, 42, 390-396
101. Chavakis, E.; Urbich, C.; Dimmeler, S. Homing and Engraftment of Progenitor Cells: A Prerequisite for Cell Therapy J. Mol. Cell Cardiol. 2008, 45, 514-522
102. Stephan, M. T.; Irvine, D. J. Enhancing Cell Therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials Nano Today 2011, 6, 309-325
103. Cheng, K.; Shen, D.; Hensley, M. T.; Middleton, R.; Sun, B.; Liu, W.; De Couto, G.; Marban, E. Magnetic Antibody-Linked Nanomatchmakers for Therapeutic Cell Targeting Nat. Commun. 2014, 5, 4880
104. Sackstein, R.; Merzaban, J. S.; Cain, D. W.; Dagia, N. M.; Spencer, J. A.; Lin, C. P.; Wohlgemuth, R. Ex Vivo Glycan Engineering of CD44 Programs Human Multipotent Mesenchymal Stromal Cell Trafficking to Bone Nat. Med. 2008, 14, 181-187
105. Won, Y. W.; Patel, A. N.; Bull, D. A. Cell Surface Engineering to Enhance Mesenchymal Stem Cell Migration toward an SDF-1 Gradient Biomaterials 2014, 35, 5627-5635
106. Stachel, G.; Trenkwalder, T.; Gotz, F.; El Aouni, C.; Muenchmeier, N.; Pfosser, A.; Nussbaum, C.; Sperandio, M.; Hatzopoulos, A. K.; Hinkel, R. SDF-1 Fused to a Fractalkine Stalk and a GPI Anchor Enables Functional Neovascularization Stem Cells 2013, 31, 1795-1805
107. Liu, Z.; Wang, H.; Wang, Y.; Lin, Q.; Yao, A.; Cao, F.; Li, D.; Zhou, J.; Duan, C.; Du, Z. The Influence of Chitosan Hydrogel on Stem Cell Engraftment, Survival and Homing in the Ischemic Myocardial Microenvironment Biomaterials 2012, 33, 3093-3106
108. Stephan, M. T.; Moon, J. J.; Um, S. H.; Bershteyn, A.; Irvine, D. J. Therapeutic Cell Engineering with Surface-Conjugated Synthetic Nanoparticles Nat. Med. 2010, 16, 1035-41
109. Szilagyi, D. E.; Smith, R. F.; Elliott, J. P.; Allen, H. M. Long-Term Behavior of a Dacron Arterial Substitute: Clinical, Roentgenologic and Histologic Correlations Ann. Surg. 1965, 162, 453-477
110. Seeger, J. M. Management of Patients with Prosthetic Vascular Graft Infection Am. Surg. 2000, 66, 166-177
111. Weinberg, C. B.; Bell, E. A Blood Vessel Model Constructed from Collagen and Cultured Vascular Cells Science 1986, 231, 397-400
112. LeBleu, V. S.; Macdonald, B.; Kalluri, R. Structure and Function of Basement Membranes Exp. Biol. Med. 2007, 232, 1121-1129
113. Brody, S.; Anilkumar, T.; Liliensiek, S.; Last, J. A.; Murphy, C. J.; Pandit, A. Characterizing Nanoscale Topography of the Aortic Heart Valve Basement Membrane for Tissue Engineering Heart Valve Scaffold Design Tissue Eng. 2006, 12, 413-421
114. Dalby, M. J.; Riehle, M. O.; Johnstone, H.; Affrossman, S.; Curtis, A. S. In Vitro Reaction of Endothelial Cells to Polymer Demixed Nanotopography Biomaterials 2002, 23, 2945-2954
115. Mohan, C. C.; Sreerekha, P. R.; Divyarani, V. V.; Nair, S.; Chennazhi, K.; Menon, D. Influence of Titania Nanotopography on Human Vascular Cell Functionality and Its Proliferation in Vitro J. Mater. Chem. 2012, 22, 1326-1340
116. Dingemans, K. P.; Teeling, P.; Lagendijk, J. H.; Becker, A. E. Extracellular Matrix of the Human Aortic Media: An Ultrastructural Histochemical and Immunohistochemical Study of the Adult Aortic Media Anat. Rec. 2000, 258, 1-14
117. Yim, E. K.; Reano, R. M.; Pang, S. W.; Yee, A. F.; Chen, C. S.; Leong, K. W. Nanopattern-Induced Changes in Morphology and Motility of Smooth Muscle Cells Biomaterials 2005, 26, 5405-5413
118. Chaterji, S.; Kim, P.; Choe, S. H.; Tsui, J. H.; Lam, C. H.; Ho, D. S.; Baker, A. B.; Kim, D. H. Synergistic Effects of Matrix Nanotopography and Stiffness on Vascular Smooth Muscle Cell Function Tissue Eng., Part. A 2014, 20, 2115-2126
119. Barnes, C. P.; Sell, S. A.; Boland, E. D.; Simpson, D. G.; Bowlin, G. L. Nanofiber Technology: Designing the Next Generation of Tissue Engineering Scaffolds Adv. Drug Delivery Rev. 2007, 59, 1413-33
120. Cui, H.; Webber, M. J.; Stupp, S. I. Self-Assembly of Peptide Amphiphiles: From Molecules to Nanostructures to Biomaterials Biopolymers 2010, 94, 1-18
121. Rajangam, K.; Arnold, M. S.; Rocco, M. A.; Stupp, S. I. Peptide Amphiphile Nanostructure-Heparin Interactions and Their Relationship to Bioactivity Biomaterials 2008, 29, 3298-3305
122. Rajangam, K.; Behanna, H. A.; Hui, M. J.; Han, X.; Hulvat, J. F.; Lomasney, J. W.; Stupp, S. I. Heparin Binding Nanostructures to Promote Growth of Blood Vessels Nano Lett. 2006, 6, 2086-2090
123. Jayaraman, K.; Kotaki, M.; Zhang, Y.; Mo, X.; Ramakrishna, S. Recent Advances in Polymer Nanofibers J. Nanosci. Nanotechnol. 2004, 4, 52-65
124. Ma, P. X.; Zhang, R. Synthetic Nano-Scale Fibrous Extracellular Matrix J. Biomed. Mater. Res. 1999, 46, 60-72
125. Thompson, C. J.; Chase, G. G.; Yarin, A. L.; Reneker, D. H. Effects of Parameters on Nanofiber Diameter Determined from Electrospinning Model Polymer 2007, 48, 6913-6922
126. Yordem, O. S.; Papila, M.; Menceloglu, Y. Z. Effects of Electrospinning Parameters on Polyacrylonitrile Nanofiber Diameter: An Investigation by Response Surface Methodology Mater. Design 2008, 29, 34-44
127. Rnjak-Kovacina, J.; Weiss, A. S. Increasing the Pore Size of Electrospun Scaffolds Tissue Eng., Part. B Rev. 2011, 17, 365-372
128. Arras, M. M. L.; Grasl, C.; Bergmeister, H.; Schima, H. Electrospinning of Aligned Fibers with Adjustable Orientation Using Auxiliary Electrodes Sci. Technol. Adv. Mater. 2012, 13 035008
129. Wu, H.; Fan, J.; Chu, C. C.; Wu, J. Electrospinning of Small Diameter 3-D Nanofibrous Tubular Scaffolds with Controllable Nanofiber Orientations for Vascular Grafts J. Mater. Sci. Mater. Med. 2010, 21, 3207-3215
130. Tsuji, H.; Nakano, M.; Hashimoto, M.; Takashima, K.; Katsura, S.; Mizuno, A. Electrospinning of Poly(Lactic Acid) Stereocomplex Nanofibers Biomacromolecules 2006, 7, 3316-3320
131. Liu, W.; Wei, J.; Chen, Y.; Huo, P.; Wei, Y. Electrospinning of Poly(L-Lactide) Nanofibers Encapsulated with Water-Soluble Fullerenes for Bioimaging Application ACS Appl. Mater. Interfaces 2013, 5, 680-685
132. Boland, E. D.; Coleman, B. D.; Barnes, C. P.; Simpson, D. G.; Wnek, G. E.; Bowlin, G. L. Electrospinning Polydioxanone for Biomedical Applications Acta Biomater. 2005, 1, 115-123
133. Li, M. Y.; Guo, Y.; Wei, Y.; MacDiarmid, A. G.; Lelkes, P. I. Electrospinning Polyaniline-Contained Gelatin Nanofibers for Tissue Engineering Applications Biomaterials 2006, 27, 2705-2715
134. Buttafoco, L.; Kolkman, N. G.; Engbers-Buijtenhuijs, P.; Poot, A. A.; Dijkstra, P. J.; Vermes, I.; Feijen, J. Electrospinning of Collagen and Elastin for Tissue Engineering Applications Biomaterials 2006, 27, 724-734
135. Perumcherry, S. R.; Chennazhi, K. P.; Nair, S. V.; Menon, D.; Afeesh, R. A Novel Method for the Fabrication of Fibrin-Based Electrospun Nanofibrous Scaffold for Tissue-Engineering Applications Tissue Eng., Part. C Methods 2011, 17, 1121-1130
136. Buttafoco, L.; Kolkman, N. G.; Poot, A. A.; Dijkstra, P. J.; Vermes, I.; Feijen, J. Electrospinning Collagen and Elastin for Tissue Engineering Small Diameter Blood Vessels J. Controlled Release 2005, 101, 322-324
137. Whited, B. M.; Rylander, M. N. The Influence of Electrospun Scaffold Topography on Endothelial Cell Morphology, Alignment, and Adhesion in Response to Fluid Flow Biotechnol. Bioeng. 2014, 111, 184-195
138. Pham, Q. P.; Sharma, U.; Mikos, A. G. Electrospun Poly(Epsilon-Caprolactone) Microfiber and Multilayer Nanofiber/Microfiber Scaffolds: Characterization of Scaffolds and Measurement of Cellular Infiltration Biomacromolecules 2006, 7, 2796-2805
139. Wise, S. G.; Byrom, M. J.; Waterhouse, A.; Bannon, P. G.; Weiss, A. S.; Ng, M. K. A Multilayered Synthetic Human Elastin/Polycaprolactone Hybrid Vascular Graft with Tailored Mechanical Properties Acta Biomater. 2011, 7, 295-303
140. Zhang, H.; Jia, X.; Han, F.; Zhao, J.; Zhao, Y.; Fan, Y.; Yuan, X. Dual-Delivery of VEGF and PDGF by Double-Layered Electrospun Membranes for Blood Vessel Regeneration Biomaterials 2013, 34, 2202-2212
141. Li, Q.; Wang, Z.; Zhang, S.; Zheng, W.; Zhao, Q.; Zhang, J.; Wang, L.; Wang, S.; Kong, D. Functionalization of the Surface of Electrospun Poly(Epsilon-Caprolactone) Mats Using Zwitterionic Poly(Carboxybetaine Methacrylate) and Cell-Specific Peptide for Endothelial Progenitor Cells Capture Mater. Sci. Eng., C 2013, 33, 1646-53
142. Agarwal, R.; Singh, V.; Jurney, P.; Shi, L.; Sreenivasan, S. V.; Roy, K. Mammalian Cells Preferentially Internalize Hydrogel Nanodiscs over Nanorods and Use Shape-Specific Uptake Mechanisms Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 17247-17252
143. Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Yang, N.; Zhao, B.; Zhang, H.; Sun, Y. M.; Zhang, L. A.; Fan, F. Y. Size-Dependent in Vivo Toxicity of PEG-Coated Gold Nanoparticles Int. J. Nanomed. 2011, 6, 2071-2081
144. Love, S. A.; Maurer-Jones, M. A.; Thompson, J. W.; Lin, Y. S.; Haynes, C. L. Assessing Nanoparticle Toxicity Annu. Rev. Anal. Chem. 2012, 5, 181-205
145. Marquis, B. J.; Love, S. A.; Braun, K. L.; Haynes, C. L. Analytical Methods to Assess Nanoparticle Toxicity Analyst 2009, 134, 425-439
146. Kuo, L. J.; Yang, L. X. Gamma-H2AX-a Novel Biomarker for DNA Double-Strand Breaks In Vivo 2008, 22, 305-309
147. Manke, A.; Wang, L.; Rojanasakul, Y. Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity Biomed. Res. Int. 2013, 2013, 942916
148. Shvedova, A. A.; Pietroiusti, A.; Fadeel, B.; Kagan, V. E. Mechanisms of Carbon Nanotube-Induced Toxicity: Focus on Oxidative Stress Toxicol. Appl. Pharmacol. 2012, 261, 121-133
149. Kennedy, I. M.; Wilson, D.; Barakat, A. I. Uptake and Inflammatory Effects of Nanoparticles in a Human Vascular Endothelial Cell Line Res. Rep.-Health Eff. Inst. 2009, 3-32
150. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles Mol. Pharmaceutics 2008, 5, 505-515
151. Frank, M. M.; Fries, L. F. The Role of Complement in Inflammation and Phagocytosis Immunol. Today 1991, 12, 322-326
152. Vasquez, K. O.; Casavant, C.; Peterson, J. D. Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging PLoS One 2011, 6 e20594
153. Kim, S. C.; Kim, D. W.; Shim, Y. H.; Bang, J. S.; Oh, H. S.; Wan Kim, S.; Seo, M. H. In Vivo Evaluation of Polymeric Micellar Paclitaxel Formulation: Toxicity and Efficacy J. Controlled Release 2001, 72, 191-202
154. Li, J.; Li, Q.; Xu, J.; Cai, X.; Liu, R.; Li, Y.; Ma, J.; Li, W. Comparative Study on the Acute Pulmonary Toxicity Induced by 3 and 20 nm TiO2 Primary Particles in Mice Environ. Toxicol. Pharmacol. 2007, 24, 239-244
155. Desai, N. Challenges in Development of Nanoparticle-Based Therapeutics AAPS J. 2012, 14, 282-295
156. Patterson, J. T.; Gilliland, T.; Maxfield, M. W.; Church, S.; Naito, Y.; Shinoka, T.; Breuer, C. K. Tissue-Engineered Vascular Grafts for Use in the Treatment of Congenital Heart Disease: From the Bench to the Clinic and Back Again Regen. Med. 2012, 7, 409-419
157. L'Heureux, N.; McAllister, T. N.; de la Fuente, L. M. Tissue-Engineered Blood Vessel for Adult Arterial Revascularization N. Engl. J. Med. 2007, 357, 1451-1453